Company news: Bod Science; Emyria by Martin Lane November 21, 2023April 30, 2024 Bod Science has yet to settle tranche one of its current capital raise following delays in […]
Company news: Emyria; Wellnex Life; Neurotech International; Melodiol Global Health by Martin Lane November 14, 2023April 30, 2024
Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics by Martin Lane October 3, 2023April 30, 2024
Emyria posts A$7m loss but insists 2023 will be ‘momentous’ by Steve Jones August 30, 2022April 29, 2024
